午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频
TargetMol中國(guó)(陶術(shù)生物) Company Information
Company Name:
TargetMol Chemicals Inc.
Tel:
-
Email:
marketing@targetmol.cn
Nationality:
China
WebSite:
https://www.targetmol.cn/
Product List:
21356
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
Product List
Izilendustat hydrochloride
1303513-80-5
HIV-1 inhibitor-43
2493426-43-8
AS1134900
149760-98-5
Carbonic anhydrase inhibitor 11
2411059-71-5
(Z)-Fluoxastrobin
887973-21-9
Topoisomerase II inhibitor 4
2560590-49-8
TDP1 Inhibitor-2
859142-95-3
GGTI-286 hydrochloride
181141-66-2
SGLT1/2-IN-1
1673514-65-2
KRAS G12C inhibitor 29
847337-63-7
Lazuvapagon
2379889-71-9
HIV-1 inhibitor-34
2395777-45-2
Myoferlin inhibitor 1
2366279-99-2
KRAS inhibitor-16
2230873-67-1
Senexin C
2375554-02-0
Bromperidol hydrochloride
59453-24-6
Rafutrombopag
2600513-51-5
EIF2α activator 2
1501618-04-7
SHP504
2222280-83-1
ZY-444
1802650-31-2
BET bromodomain inhibitor 2
2414195-69-8
Microtubule inhibitor 4
2411962-64-4
HIV-1 inhibitor-24
2475658-75-2
Nur77 modulator 2
2055829-03-1
RUSKI-201 dihydrochloride
2320262-09-5
PI3K/mTOR Inhibitor-9
1392421-71-4
TYK2-IN-12
2244061-66-1
FLT3-IN-12
2499966-67-3
Anticancer agent 32
2222930-76-7
SW02
1010820-68-4
JNc-440
1119503-63-7
TLR7 agonist 4
2413016-42-7
IHMT-MST1-58
2414484-25-4
Aurora Kinases-IN-2
2241914-86-1
Microtubule inhibitor 6
2416338-64-0
CJJ300
1807631-83-9
Microtubule inhibitor 7
2416338-65-1
Xininurad
2365178-28-3
Posenacaftor
2095064-05-2
ALOX15-IN-2
2764818-23-5
MEIS-IN-1
2761326-82-1
FLT3-IN-11
2499966-50-4
Anti-melanoma agent 1
2418579-17-4
Aha1/Hsp90-IN-1
2768265-58-1
Y08175
2223014-57-9
KRAS inhibitor-12
2230874-00-5
IDH1 Inhibitor 5
1940128-37-9
Lotrafiban
171049-14-2
VII-31
2305757-96-2
ET-JQ1-OH
2421153-77-5
Syk Inhibitor II dihydrochloride dihydrate
1965323-05-0
HIV-1 inhibitor-33
2395777-43-0
HIV-1 inhibitor-46
332947-35-0
AMPK-IN-3
2417674-27-0
Trk-IN-9
2758623-12-8
CB1/2 agonist 2
2772379-97-0
KVI-020
1000306-34-2
KRAS inhibitor-15
2230873-75-1
UNC9994 hydrochloride
2108826-33-9
hGPR91 antagonist 3
1314796-31-0
BAY 2476568
2311901-93-4
Estrogen receptor α antagonist 1
2580941-45-1
Aurora kinase inhibitor-9
2419107-09-6
CDK7/12-IN-1
2654075-94-0
Tubulin inhibitor 25
2411697-71-5
OM-1700
2406276-78-4
Dalmelitinib
1637658-98-0
KRAS inhibitor-18
2230873-66-0
Carbonic anhydrase inhibitor 7
546105-61-7
BRD4 Inhibitor-23
2760307-53-5
KRAS inhibitor-17
2230873-65-9
Haloperidol lactate
53515-91-6
CCR8 antagonist 2
2756350-98-6
GABAA receptor modulator-2
2413850-54-9
Glucosylceramide synthase-IN-1
2601393-20-6
Microtubule inhibitor 3
1236141-96-0
ERK1/2 inhibitor 7
2648455-13-2
Raltegravir sodium
1292804-07-9
TM-1
921099-13-0
Sunobinop
1126793-40-5
KRAS G12C inhibitor 53
2761968-93-6
FabG1-IN-1
1051177-61-7
BuChE-IN-1
2669070-40-8
FLT3-IN-15
2435562-99-3
TRPC6-IN-3
2311863-36-0
MARK-IN-4
1990492-86-8
GNE-9278
2315311-83-0
Topoisomerase I inhibitor 8
210346-40-0
NR2F6 modulator-1
904449-84-9
HIV-1 inhibitor-25
2475658-74-1
STAT3-IN-13
2248552-86-3
HIV-1 inhibitor-42
2459929-46-3
Aurora A inhibitor 2
2412144-74-0
GABAA receptor agent 2 TFA
1781880-44-1
VVD-118313
2875046-27-6
Vulolisib
2390105-79-8
NN-390
2490284-25-6
POLA1 inhibitor 1
2217671-41-3
FLT3/ITD-IN-4
2278278-04-7
Panamesine
139225-22-2
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
Copyright 2007© ChemicalBook. All rights reserved.